Concepedia

Shawn Bird

SB

Statistics

Publications

3

Citations

816

H-Index

3

Active since

2017

Affiliations

Yale University(Current)

Shawn Bird is an author at Yale University specializing in medicine, pharmacology, and clinical trials.

Top concepts

MedicinePharmacologyClinical TrialsPharmacotherapyClinical Epidemiology

Publications per year

2017–2024

3

Publications

3

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study

Pushpa Narayanaswami, Donald B. Sanders, Laine Thomas et al. · The Lancet Neurology · 2024 · 44 citations

Mycophenolate Mofetil, Clinical Epidemiology, Clinical Trials +5

Single institution experience with efgartigimod in patients with myasthenia gravis: Patient selection, dosing schedules, treatment response, and adverse events

Madeline L. Singer, Sami Khella, Shawn Bird et al. · Muscle & Nerve · 2023 · 27 citations · Full text

1–3 of 3